- Home
- BBUC vs BCRX Comparison
BBUC vs BCRX Comparison
Compare BBUC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBUC | BCRX |
|---|---|---|
| Founded | 2022 | 1986 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BBUC | BCRX |
|---|---|---|
| Price | $33.89 | $9.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $41.00 | $20.82 |
| AVG Volume (30 Days) | 197.1K | ★ 3.5M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.55 |
| P/E Ratio | ★ N/A | $7.60 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.19 | $6.00 |
| 52 Week High | $38.25 | $11.31 |
Technical Indicators
Market Signals| Indicator | BBUC | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.79 | 53.23 |
| Support Level | $30.99 | $7.99 |
| Resistance Level | $35.22 | $10.15 |
| Average True Range (ATR) | 0.83 | 0.37 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 50.63 | 58.26 |
Price Performance
Historical ComparisonAbout BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.